BLi-T

BLi-T is an emerging biotechnology company focused on developing a novel therapeutic platform known as Bioluminescence-Induced Therapy. The company's core technology utilizes bioluminescent systems to activate light-sensitive prodrugs or photosensitizers directly within the tumor microenvironment, overcoming the penetration depth limitations of traditional photodynamic therapy. By leveraging internal light generation, BLi-T aims to provide a highly targeted, non-invasive treatment modality for deep-seated solid tumors. The company is currently in the pre-clinical stage, optimizing its bioluminescent delivery systems and expanding its pipeline of light-activated therapeutic agents.